# Candida albicans releases a peptide from the Rbt1 protein to promote its invasion into the gut epithelium

Hervé Bègue, Amandine Ducreux, Tracy Paradis, Alicia Loiselet, Thierry Mourer, Géraldine Lucchi, Sylvie Kieffer-Jaquinod, Yohann Coute, Bernhard Hube, Ilias Theodorou, et al.

► To cite this version:

Hervé Bègue, Amandine Ducreux, Tracy Paradis, Alicia Loiselet, Thierry Mourer, et al. Candida albicans releases a peptide from the Rbt1 protein to promote its invasion into the gut epithelium. Gut microbes, 2025, 17 (1), pp.2573038. 10.1080/19490976.2025.2573038. pasteur-05441593

HAL Id: pasteur-05441593

https://pasteur.hal.science/pasteur-05441593v1

Submitted on 5 Jan 2026

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons CC BY 4.0 - Attribution - International License
<figure><img src="image_2.png" /></figure>

*Candida albicans* releases a peptide from the Rbt1 protein to promote its invasion into the gut epithelium

Hervé Bègue, Amandine Ducreux, Tracy Paradis, Alicia Loiselet, Thierry Mourer, Géraldine Lucchi, Sylvie Kieffer-Jaquinod, Yohann Coute, Bernhard Hube, Ilias Theodorou, Sophie Thenet, Benjamin Gillet, Sandrine Hughes, Pierre Lapaquette, Louise Basmaciyan, Sophie Bachellier-Bassi, Christophe d'Enfert, Fabienne Bon & Frédéric Dalle

**To cite this article:** Hervé Bègue, Amandine Ducreux, Tracy Paradis, Alicia Loiselet, Thierry Mourer, Géraldine Lucchi, Sylvie Kieffer-Jaquinod, Yohann Coute, Bernhard Hube, Ilias Theodorou, Sophie Thenet, Benjamin Gillet, Sandrine Hughes, Pierre Lapaquette, Louise Basmaciyan, Sophie Bachellier-Bassi, Christophe d'Enfert, Fabienne Bon & Frédéric Dalle (2025). *Candida albicans* releases a peptide from the Rbt1 protein to promote its invasion into the gut epithelium, Gut Microbes, 17:1, 2573038, DOI: 10.1080/19490976.2025.2573038

**To link to this article:** https://doi.org/10.1080/19490976.2025.2573038

<figure><img src="image_3.png" /></figure>

© 2025 Université de Bourgogne Europe.

<figure><img src="image_4.png" /></figure>

View supplementary material 🌐

<figure><img src="image_5.png" /></figure>

Published online: 30 Oct 2025.

<figure><img src="image_6.png" /></figure>

Submit your article to this journal 🌐

<figure><img src="image_7.png" /></figure>

Article views: 1186

<figure><img src="image_8.png" /></figure>

View related articles 🌐

<figure><img src="image_9.png" /></figure>

CrossMark

View Crossmark data 🌐

<figure><img src="image_10.png" /></figure>
<figure><img src="image_11.png" /></figure>

RESEARCH ARTICLE

<figure><img src="image_12.png" /></figure>

OPEN ACCESS

<figure><img src="image_13.png" /></figure>

Check for updates

# Candida albicans releases a peptide from the Rbt1 protein to promote its invasion into the gut epithelium

Hervé Bègue<sup>a,b,1</sup> ID, Amandine Ducreux<sup>a,1</sup>, Tracy Paradis<sup>a</sup> ID, Alicia Loiselet<sup>a,b</sup>, Thierry Mourer<sup>c</sup>, Géraldine Lucchi<sup>d</sup> ID, Sylvie Kieffer-Jaquinod<sup>e</sup> ID, Yohann Coute<sup>e</sup> ID, Bernhard Hube<sup>f,g</sup> ID, Ilias Theodorou<sup>h</sup> ID, Sophie Thenet<sup>h,i</sup> ID, Benjamin Gillet<sup>j</sup> ID, Sandrine Hughes<sup>l</sup> ID, Pierre Lapaquette<sup>a</sup> ID, Louise Basmaciyan<sup>a,b</sup> ID, Sophie Bachellier-Bassi<sup>c</sup> ID, Christophe d'Enfert<sup>c</sup> ID, Fabienne Bon<sup>a,2</sup> ID and Frédéric Dalle<sup>a,b,2</sup> ID

## ABSTRACT

Candida albicans has been recently added to the WHO critical priority group of fungal pathogens based on its impact on global public health. C. albicans is a mucosal commensal yeast in humans that can cause severe gastrointestinal-borne disseminated candidiasis in immunocompromised patients. C. albicans interaction with enterocytes is thus a key step in the pathophysiology of disseminated candidiasis. Here, we show that, during the first steps of the infection process, C. albicans releases a peptide from the Repressed by Tup1 protein 1 (Rbt1), which disorganizes the cell-cell adhesion junctions in Caco-2 intestinal epithelial cells by notably downregulating constitutive proteins of the tight junction complex (i.e. ZO-1). This is the first report to show that a peptide of a human pathogenic fungus promotes fungal invasion into the gut epithelium by disorganizing the protective epithelial barrier.

## ARTICLE HISTORY

Received 28 April 2025
Revised 2 October 2025
Accepted 6 October 2025

## KEYWORDS

Rbt1; Candida albicans; enterocytes; tight junctions

## Introduction

Candida albicans is a fungal pathobiont residing as a commensal on the surface of mucosa in healthy humans as the result of a balanced interplay between the fungus, the microbiome, and host defenses. Disruption of this balance triggers the expression of fungal traits associated with pathogenicity.<sup>1-7</sup> Consequently, C. albicans behaves as an opportunistic pathogen that can be responsible for infections ranging from superficial to disseminated candidiasis in vulnerable individuals. Disseminated candidiasis is mainly due to excessive colonization of the gut mucosa followed by the translocation of the fungus through the gut barrier in immunocompromised patients.<sup>5,8,9</sup> Therefore, the interaction between C. albicans and intestinal epithelial cells IEC is crucial either during the establishment of commensalism or during the successive steps of fungal infection.<sup>10,11</sup>

To translocate through epithelial layers and damage epithelial cells, C. albicans has developed several strategies whereby the yeast-to-hyphae transition plays a pivotal role.<sup>12,13</sup> Whereas both trans- and paracellular translocation routes have been reported,<sup>12,14</sup> transcellular crossing remains the main mechanism associated with epithelial cell damage. This involves two mechanistically distinct routes of invasion: (i)

**CONTACT** Frederic Dalle frederic.dalle@u-bourgogne.fr UMR PAM Univ Bourgogne Europe - Institut Agro Dijon - INRAE, Equipe Aliment, Fermentation, Interaction, Microbiote - AFIM, UFR Sciences de Santé, 7, Boulevard Jeanne d'Arc, BP 87900, F-21079 Dijon Cedex, France
¹Equal contribution for first authorship.

²Equal contribution to last authorship.

<figure><img src="image_14.png" /></figure>

Supplemental data for this article can be accessed online at https://doi.org/10.1080/19490976.2025.2573038.

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

<footnote><sup>a</sup>UMR PAM Univ Bourgogne Europe - Institut Agro Dijon - INRAE, Equipe Aliment, Fermentation, Interaction, Microbiote - AFIM, UFR Sciences de Santé, Dijon, France; <sup>b</sup>University Hospital Center, Parasitology Mycology department, Dijon, France; <sup>c</sup>Institut Pasteur, Université Paris Cité, INRAE USC2019, Unité Biologie et Pathogénicité Fongiques, Paris, France; <sup>d</sup>University Hospital Center, Platform CLIPP, Dijon, France; <sup>e</sup>Univ. Grenoble Alpes, INSERM, CEA, UA13 BGE, CNRS, CEA, Grenoble, France; <sup>f</sup>Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knoell Institute (HKI), Jena, Germany; <sup>g</sup>Institute of Microbiology, Faculty of Biological Sciences, Friedrich Schiller University, Jena, Germany; <sup>h</sup>Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, Paris, France; <sup>i</sup>EPHE PSL University, Paris, France; <sup>j</sup>Plateforme de Séquençage de l'IGFL, Lyon, France</footnote>
<figure><img src="image_15.png" /></figure>

epithelial-driven endocytosis of *C. albicans* hyphal tips, involving the interaction of fungal hyphal-associated surface invasins with defined membrane epithelial receptors (including E-cadherin, EGFR/HER2 and c-Met),¹⁵ and (ii) the active penetration of fungal hyphae is potentiated by the release of fungal components. Whereas epithelial endocytosis initiates and potentiates the invasion process of *C. albicans* hyphae into epithelial cells, active penetration of hyphae exerts a pressure upon infected epithelial cell surfaces that strongly deforms epithelial plasma membranes, creating a pocket of epithelial invasion favoring the accumulation of fungal molecules secreted extracellularly by *C. albicans* hyphae. In fine, epithelial cell damage is attributed to the mechanical deformation of plasma membranes driven by hyphal growth in association with the cytotoxicity induced by secreted fungal molecules. These molecules include secreted hydrolases and the pore-forming toxin candidalysin, whose functions have been well described as inducing alterations in cellular junctions and the plasma membrane, tissue damage, inflammasome activation, and finally cell death.¹⁰,¹¹,¹⁵⁻²¹

Whereas both invasion routes require initial adhesion of the fungus to epithelial cells,¹¹ cellular endocytosis of *C. albicans* was initially described as a cell type-dependent mechanism observed in both vaginal and oral-epithelial cells.¹⁷,²² In contrast, in IEC the tight junction (TJ) complex limits fungal invasion by masking epithelial receptors involved in the induction of the endocytic pathway.²³ Interestingly, we have previously shown that pharmacologically altering the TJ complex facilitates *C. albicans* invasion into IEC by allowing interaction of fungal invasins with epithelial cell receptors triggering the endocytic machinery.²³

Here, we report early gut barrier breakdown by *C. albicans* cells interacting with polarized IECs, namely, Caco-2 cells, correlated with the downregulation of cell-cell adhesion proteins, including different constitutive proteins of the TJ complex. While this pathogenic process does not require *C. albicans*-IEC contact, it does involve *C. albicans*-secreted molecules, including a peptide released from the Repressed by Tup 1 (Rbt1) protein. Whereas this fungal GPI-anchored cell wall protein was previously reported to be involved in mating efficiency, biofilm formation, adhesion to cell surface proteins of the host and in cell-cell aggregation,²⁴⁻²⁶ we report herein the discovery of a novel function of Rbt1 as a virulence factor weakening the barrier function of the gut layer. This mechanism secondarily favors *C. albicans* invasion into IECs during the early stages of the infection process.

## Materials and methods

### Intestine epithelial cell (IEC) line and growth conditions

The Caco-2 intestinal epithelial cell line derived from a human colon adenocarcinoma (ATCC n°HTB-37™) was grown in Dulbecco's modified Eagle's medium (Glutamax and high glucose, 4.5 g L⁻¹) (DMEM) (Gibco, Life Technologies) supplemented with 10% (v/v) FBS (PAN Biotech) and 0.1 mM non-essential amino acid mixture (Dominique Dutscher). For permeability assays (TEER and LY) and microscopic observation of TJ proteins after immunofluorescence staining, cells were seeded on Transwell® inserts (polyethylene terephthalate membrane, pore size = 0.4 µm, effective growth area of the membrane = 0.3 cm²) (Falcon, Corning) at a rate of 1.25 × 10⁵ cells per well. Evaluation of Caco-2 cell monolayer grown on permeable supports complied microscopic observation of the aspect of the cell monolayer and routine TEER measurements. If the TEER value of a well was less than 1400 Ω.cm², this well was rejected. For the WB and invasion assays, 2.5 × 10⁵ cells were seeded onto 14 mm diameter glass coverslips in 24-well plates. The cells were maintained in a humidified incubator at 37 °C with 5% CO₂, and the medium was changed every 2–3 d. The cells were passed every 7 d in flasks. They were used for experiments 15 to 21 d after seeding (passages 10–20).

### C. albicans strains and growth media

*C. albicans* SC5314 (*Ca*-SC5314) was used for all the assays as a wild-type strain.²⁷ To clarify the role of *C. albicans* on tight junction alteration, different mutants were used as specified in Table 1. All strains were maintained on solid Sabouraud dextrose agar 2% (m/v) with gentamicin and chloramphenicol (BD). The *rbt1ΔKR* mutant was constructed in the *rbt1* KO mutant as follows: the 3'UTR region of *RBT1* was
<figure><img src="image_16.png" /><figcaption>**Table 1.** *C. albicans* strains used in this study.</figcaption></figure>

<table><caption>**Table 2.** Oligonucleotides used in this study.</caption><thead><tr><th>Strain name</th><th>Strain/gene function</th><th>Relevant genotype</th><th>Reference</th></tr></thead><tbody><tr><td>SC5314</td><td>Wild-type</td><td></td><td>[27]</td></tr><tr><td>CAI-4</td><td>Parental strain (rbt1Δ/Δ)</td><td>ura3Δ:λimm<sup>434</sup>/ura3Δ:λimm<sup>434</sup></td><td>[29]</td></tr><tr><td>CAY171</td><td>Parental strain (rbt1KR)</td><td>arg4Δ/arg 4Δ rbt1Δ:LEU2/rbt1Δ:HIS1</td><td>[24]</td></tr><tr><td>rbt1Δ/Δ</td><td>Adhesion and biofilm formation</td><td>rbt1Δ:hisG/rbt1Δ:hisG-URA3-hisG ura3Δ:λimm<sup>434</sup>/ura3Δ:λimm<sup>434</sup></td><td>[30]</td></tr><tr><td>kex2Δ/Δ</td><td>Killer expression 2, serin protease</td><td>arg4Δ/arg4Δ kex2Δ:LEU2/kex2Δ:HIS1</td><td>[31]</td></tr><tr><td>rbt1ΔKR</td><td>Deletion of -KR- dipeptide flanking the RBT1 coding region (rbt1ΔKR<sup>59-60ΔKR<sup>73-74</sup></sup>)</td><td>arg4Δ/ARG4 rbt1Δ:LEU2/rbt1Δ:HIS1 P<sub>RBT1</sub>-V5-rbt1<sup>ΔK59,R60,K73,R74</sup>-SAT1</td><td>This study</td></tr></tbody></table>

<table><thead><tr><th>Name</th><th>Sequence</th></tr></thead><tbody><tr><td>ThM3</td><td>CATTTTATCCACTGAGGCTACTTTCC</td></tr><tr><td>ThM4</td><td>CAGAAGAATCACTCTTGAAGTTACAATC</td></tr><tr><td>ThM12</td><td>ATCAATACCATAAGAACCGTCAGATAATTTTTTGGCATTAGACACGACAAATGCGGCATTGAAACCGGCATTTACACCA GCGCTTCCAAAAGTTTCAATTGTACCATCTTTATTGGCAAT</td></tr><tr><td>ThM62</td><td>GACTTGGGTCTTTACCACGATAGCTCCATTTCTCTTGGTGGTTCAAAGAACGGTAAACCAATTCCAAATCCATTGTTGGG TTGGATTCACTGAAGCTGAAATTGCCAATAAAGATGGT</td></tr><tr><td>ThM81</td><td>ATCACTCGAGTTAGATCAAGAATGCAGCAAGACCAATAATAG</td></tr><tr><td>ThM82</td><td>ATCAGGTACCCATAATGTGATATTTGATAACTCTGGCACAG</td></tr><tr><td>ThM85</td><td>ATCAGAGCTCTTCTAGTTACTGATACTATATCTTTTTCTTTTTC</td></tr><tr><td>ThM86</td><td>ATCACCGCGGGTATCCTAACCATTAAATCTTTAATCGCCGAAC</td></tr></tbody></table>

amplified on *Ca*-SC5314 genomic DNA using primers ThM85 and ThM86 (Table 2) with high-fidelity polymerase Q5 according to the manufacturer's instructions; the fragment was then digested with SacI and SacII and inserted into pSFS2A cut with the same enzymes, yielding pSFS2A-3'UTR<sub>RBT1</sub>. The *RBT1* coding sequence mutated for the two proximal Kex2 sites was obtained by fusion PCR; two PCR fragments were amplified with Q5 polymerase on *Ca*-SC5314 genomic DNA with the primers ThM82 and ThM12, and ThM62 and ThM81, respectively, introducing deletions of K59, R60, K73, and R74. The two fragments were then fused using primers ThM82 and ThM81. The resulting fragment was digested with KpnI and XhoI and inserted into the pSFS2A-3'UTR<sub>RBT1</sub> cut similarly, yielding pSFS2A-*RBT1*<sup>ΔK59,R60,K73,R74</sup>. The plasmid was digested with KpnI and SacI, and the fragments used to transform *C. albicans* using the lithium acetate-PEG protocol.<sup>28</sup> The transformants were selected on YPD medium supplemented with 200 µg mL<sup>-1</sup> nourseothricin after 48 h of incubation at 30 °C. Proper integration at the *RBT1* locus was checked by PCR using the primers ThM3 and ThM4.

For the experiments, after an overnight growth on YPD broth (MP Biomedicals) at 37 °C, 300 rpm in an Ecotron incubator (Infors HT), *C. albicans* cells were diluted in fresh liquid YPD to an OD<sub>600 nm</sub> of 0.28 to 0.32 and grown to log phase for another 2 h under the same conditions. The cells were then adjusted to the desired concentration in DMEM without FBS.

For “killing” assays, the yeasts were incubated in phosphate-buffered saline (PBS, 8 mM Na<sub>2</sub>HPO<sub>4</sub>, 2 mM KH<sub>2</sub>PO<sub>4</sub>, 140 mM NaCl, 2.7 mM KCl, pH 7.2) containing 0.04% (m/v) Thimerosal (2-[ethylmercuriomercapto] benzoic acid sodium salt, Sigma) for 1 h at room temperature on a shaking plate. After washing them three times with PBS, they were adjusted to the desired concentration in DMEM. Fungal inhibition was confirmed by plating 100 µL of treated cells on Sabouraud agar.

## Secretome production

Different supernatants of *C. albicans* subcultures were obtained in DMEM w/o FBS at 37 °C in an Ecotron incubator (Infors HT) (300 rpm) either at 10<sup>7</sup> yeasts mL<sup>-1</sup> for one to four h or at 5.3 × 10<sup>7</sup> yeasts mL<sup>-1</sup> for 1 h. After centrifugation for 10 min at 1065 g, the supernatant was sterilized by filtration. For determination of the size of the molecule of interest, different Amicon Ultra 15 mL centrifugal filters (Merck, Millipore) were used. All the supernatants were tested without any dilution. The samples were directly used or stored at -20 °C for up to one week.
<figure><img src="image_17.png" /></figure>

## Physical analysis by ATR-FTIR

Fourier transform infrared (FTIR) spectra were acquired by attenuated total reflection (ATR) using a Thermo Scientific Nicolet iS5. Candida supernatant and DMEM medium were gently placed on the surface of the diamond crystal and pressed with a constant force with a torque screwdriver. Each spectrum was recorded from 650 to 4000 cm⁻¹ with a 4 cm⁻¹ resolution resulting from the accumulation of 32 scans.

## Synthesized peptides

Rbt1 peptides were dissolved in acetonitrile:H₂O (1:3) as recommended by the manufacturer (Proteogenix) at a stored concentration of 22 mM (Table 3). They were used at concentrations comprised between 0.1 and 100 µM in DMEM, with the absence of cell cytotoxicity being systematically verified (10–100 µM).

## Invasion and adherent assays of C. albicans in Caco-2 cells

Invasion and adherence assays of C. albicans on Caco-2 cells were performed as previously described.¹⁷ Briefly, intestinal cells cultured on coverslips or inserts were infected at MOI 0.1 for 30 min (adherence) or 2 h (invasion) at 37 °C with C. albicans killed or not. Infected cells were fixed with 4% (v/v) PFA. The adherent part of C. albicans was stained with a rabbit polyclonal antibody (Acris Antibodies) and Alexa-Fluor 568 goat anti-rabbit antibody (Life Technology). After permeabilization of the monolayers, both the adherent and internalized fungal parts were stained using the anti-C. albicans antibody and then with Alexa-Fluor 488 goat anti-rabbit antibody (Life Technology). Coverslips were observed with a BX51 fluorescence microscope at ×40 magnification (Olympus). The percentage of invading C. albicans cells was determined by dividing the number of total or partially internalized cells by the total number of interacting Candida cells (i.e. adherent + invading cells). At least 100 fungal cells were counted on each coverslip, and all experiments were performed in duplicate in at least three independent experiments.

The contribution of intestinal cell endocytosis in the internalization of C. albicans was investigated using cytochalasin D (CytD), an inhibitor of endocytosis.¹⁷,³² Invasion assays were performed as described above, except that the Caco-2 cells were pre-treated for 30 min at 37 °C with 0.5 µM CytD (Sigma) or with an equivalent amount of its solvent (i.e. DMSO) as a control. Caco-2 cells were further incubated with the inhibitor throughout the infection period. Both innocuities of CytD and DMSO on Caco-2 and Candida cells were verified elsewhere at the concentrations used in this study.¹⁷

## Evaluation of tight junction integrity

The integrity of the tight junctions and the permeability of the epithelial monolayer were studied by monitoring the passage of Lucifer Yellow (LY) during infections (in the presence of yeasts) or by measuring the transepithelial electrical resistance (TEER) when Caco-2 cells were treated either with supernatant or with peptides. TEER was measured using a Millicell-ERS volt-ohmmeter (MerkMillipore). Before each experiment, the differentiation of the Caco-2 monolayer was argued by TEER values between 450 and 800 Ω cm².³³,³⁴ As initial TEER values vary among different Caco-2 cell monolayers, all the TEER values are expressed as percentage relative to the initial value of each culture.

An increase in permeability was confirmed by evaluating the paracellular transport of the fluorescent molecule Lucifer Yellow (LY) (457 Da) (Sigma) across Caco-2 monolayers. IEC cultured on transwell inserts were incubated with non-cytotoxic concentration of LY (1 mg mL⁻¹), either in DMEM or together with C. albicans strains. After 7 h of incubation, the quantity of LY that crossed from the apical to the

<table><caption>**Table 3.** Amino acid sequences of peptides used in this study. Rbt1 protein accession number Q59TP.</caption><thead><tr><td>Name</td><td>Position</td><td>Amino acid sequence</td></tr></thead><tbody><tr><td>sRbt1<sup>61-72</sup></td><td>61-72</td><td>EAIEANKDGTIE</td></tr><tr><td>sRbt1<sup>227-242</sup></td><td>227-242</td><td>ELDEFEELSNDGVTHS</td></tr><tr><td>sRbt1<sup>61-72s</sup></td><td>Scrambled peptide of sRbt1<sup>61-72</sup></td><td>DEGIKNETAEAI</td></tr><tr><td>sRbt1<sup>227-242s</sup></td><td>Scrambled peptide of sRbt1<sup>227-242</sup></td><td>DGVEHTSELDENSFLE</td></tr></tbody></table>
<figure><img src="image_18.png" /></figure>

basal chamber was assessed by measuring the fluorescence using SAFAS, Monaco, and XENIUS XC ($\lambda_{ex}$ = 425 nm, $\lambda_{em}$ = 540 nm). The quantity of LY was determined based on the difference in fluorescence ($T_{7h}-T_{0h}$). All values are expressed as percentage relative to the control.

## Immunofluorescence staining of junctional proteins of Caco-2 cells and image analyses

After the experiments, Caco-2 monolayers were rinsed twice with cold PBS + (1 mM CaCl₂, 0.5 mM MgCl₂ in PBS). They were fixed and permeabilized with methanol for 5 min at -20 °C and then blocked for 2 h with 3% (m/v) BSA in PBS+. Tight junctions were revealed using the monoclonal mouse (IgG1) anti-ZO1 antibody (clone ZO1-1A12, Thermo Fischer Scientific) at 4 °C overnight, followed with a goat anti-mouse (IgG) antibody conjugated with AlexaFluor 568 (Invitrogen) for 1 h at room temperature. Finally, the cells were examined with a BX51 epifluorescence microscope (Olympus). For each biological replicate (n = 3), at least 20 pictures were acquired with a 60× objective lens using Cell F software, each time with the same exposure parameters and a resolution of 4080 × 3072 pixels.

For picture analysis, the automatic spectral stretching was done using the Fiji software to evaluate the regularity/continuity of ZO-1 labeling at cell-cell contacts. Then, at least 30 segments of membrane were manually defined, with a mean length of 300 pixels. Particular attention was given to selecting segments that were as straight as possible. The sub-images were cropped to isolate the given segment. Finally, the fluorescence signal value was acquired throughout the segment.

## Immunoblotting of tight junction proteins

IEC membrane proteins were extracted with ProteoExtract® Native Membrane Protein Extraction Kit following the manufacturer protocol (Calbiochem). The protein concentration was determined using Bicinchoninic Acid Kit (Sigma-Aldrich). IEC whole-cell proteins were extracted by directly adding 200 µL of 1.25× Laemmli sample buffer (Bio-Rad) to the cell monolayers. The lysates were then disrupted by sonication for 5 min, and the proteins were denatured by heating at 95 °C for 5 min. Protein extracts were clarified by centrifugation for 10 min at 4000 × g at room temperature.

Equal quantity of membrane proteins or equal volume of total lysate were subjected to SDS-PAGE (4-15% mini-Protean precast protein gel, Bio-Rad) and transferred to nitrocellulose membrane (Trans-blot turbo, Bio-Rad). After blocking for 1 h with 3% bovine serum albumin (Sigma), the membrane was incubated overnight at 4 °C with anti-GAPDH (clone 258, Invitrogen), anti-occludin (clone OC-3F10, Invitrogen®) and anti-ZO-1 (clone ZO1-1A12, Thermo Fischer Scientific) primary antibodies as recommended by the manufacturers. A goat anti-rabbit or anti-mouse IgG (H + L) DyLight™ 680 and 800 Conjugate (Cell Signaling) antibody was used as the secondary antibody. The blots were developed using Odyssey® Fc Imaging System (LI-COR®) and analyzed with Image Studio Lite 5.2. software.

## Statistical analysis

All the experiments were conducted independently at least three times. The bar plot shows the mean of the replicates with standard error (SEM). Details of each analysis are indicated in the figure legends.

## Results

### C. albicans infection of IEC is associated with an early increase in paracellular permeability that correlates with the loss of proteins in the TJ complex

For better understanding, a diagram illustrates the study strategy used here (Figure S1). The permeability of IEC monolayers challenged with C. albicans was first investigated using trans-epithelial electrical resistance (TEER) as a readout of permeability (Figure S2a-c). Two inocula of C. albicans were tested, mimicking the yeast burden during gut colonization (multiplicity of infection (MOI) 0.1) and infection (MOI 10).¹⁶,³⁵ An increase in TEER values was observed during the first 6 h of C. albicans challenge. This
<figure><img src="image_19.png" /></figure>

increase was more pronounced at MOI of 10 compared to MOI of 0.1 (Figure S2a). However, it was not specific to *C. albicans* interaction since similar TEER value modulations were observed when challenging IEC with other pathogenic (i.e. *Nakaseomyces glabratus*, Figure S2b) or non-pathogenic (i.e. *Saccharomyces cerevisiae*, Figure S2c) yeasts. Interestingly, other authors observed a similar increase in TEER values in the early steps of infection of the Caco-2/BBe2.1 cell line by *C. albicans* at MOI of 1, classifying this phenomenon as unspecified.¹⁶ Thus, we hypothesized that the increase in TEER observed in the early stages of infection resulted from the accumulation and/or proliferation of yeasts on the apical side of the monolayer, which artifactually strengthened the fungal/IEC barrier. In the context of fungal infection, TEER measurements were considered inadequate to assess IEC permeability in the early stages of infection by *C. albicans*.

To circumvent this technical bias, we assessed the paracellular permeability of IEC by monitoring the passive paracellular transport of the fluorescent small molecule Lucifer Yellow (LY) through IEC monolayers challenged with *C. albicans* at MOI of 0.1 and 10. The accumulation of LY was detectable under all the conditions tested from 1 h to 3 h post-infection (p.i.), as the result of a basal passive transmigration of small molecules through IEC layers, as already reported.³⁶ However, an increase in LY accumulation was observed in the basal compartment of IEC monolayers infected with *C. albicans* at MOI of 10 from 4 h p.i., which was significant from 7 h p.i. (Figure 1a). This observation was consistent with barrier breakdown occurring in the 0–7 h time-period of *C. albicans* infection at MOI of 10, which was exclusively due to an increase in paracellular permeability, since no IEC cytotoxicity was observed during this time-period (Figure S3). Moreover, this result was specific to the *C. albicans* species (Figure S2d).

To specify the kinetics of gut barrier breakdown induced by *C. albicans* infection at MOI of 10, quantification of ZO-1 and occludin proteins was used as a marker of TJ integrity by western blotting IEC protein extracts at 2, 4, and 6 h p.i. (Figures 1b, S4a and S4b). As the paracellular transport of LY mainly involves membrane protein complexes,³⁶ the protein-extraction protocol was selected to enrich membrane proteins as well as proteins associated with membranes. We showed a decrease in both ZO-1 and occludin markers from 4 h p.i. in IEC infected with *C. albicans* at MOI of 10 compared to control cells (Figures 1b, S4a and S4b).

Collectively, these data showed that *C. albicans* loads, corresponding to infection, increase IEC paracellular permeability in the early stages of infection. This phenomenon is correlated with the modulation of proteins in the TJ complex.

a

<figure><img src="image_20.png" /></figure>

b

<figure><img src="image_21.png" /></figure>

**Figure 1.** *C. albicans* increases the paracellular permeability of Caco-2 monolayers at the early stage of infection. (a) Caco-2 cells were seeded on Transwell inserts, and experiments were performed after complete differentiation. The monolayer was infected in the apical chamber with two different inocula of *C. albicans* at MOI of 0.1 or 10, and the medium was supplemented with Lucifer Yellow (LY) (1 mg mL⁻¹). At each time point, the passage of the LY to the basal chamber was assessed by fluorescence measurement, which was normalized by the basal fluorescence at the onset of infection. Bar plots represent the mean ± SEM of the relative amount of LY detected. For each time point, the value was compared to the uninfected monolayer (Dunn test, *p* < 0.05, **p** < 0.01, Nb of replicates = 3). (b) Western blot (IB) against ZO-1 and occludin (Occ). A Caco-2 monolayer was infected with *C. albicans* (Ca) for 2, 4, or 6 h. Ten micrograms of membrane proteins and proteins associated with them were used for each experiment. The results depicted here are representative of 3 independent experiments.
<figure><img src="image_22.png" /></figure>

**C. albicans-secreted peptides are sufficient to induce barrier breakdown associated with a loss of tight junction proteins.**

C. albicans interacts with host cells through physical contact and/or via the secretion of molecules (e.g. peptides and/or proteins), or extracellular vesicles EV containing macromolecules such as functional proteasome complexes.³⁷⁻³⁹ Aimed at specifying whether the early increase in permeability was mediated by enterocyte-fungal cell contact or by fungal secreted molecules, we assessed the ability of C. albicans culture supernatants to modulate IEC permeability by measuring the TEER variation of IEC monolayers (Figure 2a). The treatment of IEC for 1 h 30 min with sterile C. albicans supernatants from a 4 h-culture of 10⁷ C. albicans mL⁻¹ (i.e. corresponding to MOI of 10), significantly increased IEC monolayer permeability. The treatment was 50% less efficient when using supernatants from a 1 h culture of 10⁷ C. albicans mL⁻¹.

These observations strongly suggest that secreted molecules were sufficient to alter the permeability of IEC. However, the fungal form that is able to release effective molecules remains to be specified since supernatants were obtained from cultures of mixed fungal forms (i.e. yeast, pseudohyphal, and hyphal forms, in respective proportion of 11.0 ± 1.3%, 35.3 ± 4.2%, and 53.7 ± 3.9%) (Figure 2a). We consequently optimized supernatant production and treated IEC with supernatants of a 1 h culture from a higher starting inoculum of 5.3 × 10⁷ C. albicans mL⁻¹, which displayed only yeast forms. Interestingly, the supernatants obtained under these conditions showed similar efficiency to the one observed with a 4 h-culture of 10⁷ C. albicans mL⁻¹ (Figure 2a). These observations provided evidence that C. albicans yeast forms are sufficient for the release of active molecules able to alter the TJ complex. Supernatants were obtained from a 1 h culture of 5.3 × 10⁷ C. albicans mL⁻¹ were used for further experiments and named Ca-secretome.

To specify the molecular mechanisms involved in intestinal barrier breakdown, the ZO-1 protein level and spatial distribution were used as markers of TJ integrity⁴⁰ (Figures 2b-d, S4). For both conditions, i.e.

<figure><img src="image_23.png" /><figcaption>**Figure 2.** C. albicans supernatant is able to modulate the Caco-2 monolayer integrity. Caco-2 cells were seeded on Transwell inserts, and experiments were performed after complete differentiation. (a) Cells were treated with C. albicans supernatants in the apical chamber for 1 h 30. Conditions of supernatant production are specified beneath the graphic, in terms of yeast culture duration and/or starting inoculum. The monolayer integrity was assessed using TEER measurement just after adding the supernatant and at the end of the incubation period. The results are displayed as the mean ± SEM percentage of TEER variation compared to the untreated condition (n = 3). (b) Immunolabelling of the ZO-1 protein on the Caco-2 monolayer after 1 h 30 min of infection with C. albicans at MOI of 10 or treatment with C. albicans supernatant (10⁷ yeasts mL⁻¹, 4 h-culture). The white arrows highlight cell-cell separation or thickening of ZO-1 signal, while dark arrows highlight zigzag structures. (c) For immunolabelling experiment, image analysis was performed as explained in Figure S5. Violin plots displaying differences in ZO-1 signal dispersion (A.U.). The higher the value is, the wider is the ZO-1 signal at the cell-cell contact zone. For this representation, more than 35 000 signals were analyzed. The horizontal line represents the median value. Statistical differences were examined by one-tailed T-test; H₀: mean of dispersion ≤ mean of dispersion for the untreated condition (*p* < 0.01). (d) Western blot against ZO-1. Caco-2 monolayer was infected with C. albicans at MOI of 10 or treated with C. albicans supernatant (10⁷ yeasts mL⁻¹, 4 h production) for 2, 4, or 6 h. The whole proteins were extracted, and 5 µL was deposited. The results depicted here are representative of 3 independent experiments.</figcaption></figure>
<figure><img src="image_24.png" /></figure>

C. albicans IEC infection and IEC treatment with the Ca-secretome, ZO-1 protein levels dramatically decreased in the total IEC protein lysate after 2 h of contact compared to the control condition (Figures 2d and S4c). Importantly, this was not correlated to a decrease in the level of ZO-1 gene expression (Figure S5). In parallel, microscopic observations revealed tortuous and irregular patterns of ZO-1 immunolabelling (Figure 2b). However, the alteration in ZO-1 distribution differed depending on the treatment conditions. The fluorescence distribution presented discontinuities after 2 h of C. albicans infection at MOI of 10, highlighting a gap between the cells (Figure 2b, central panel). In contrast, diffuse signals or zigzag patterns were mainly observed after 2 h of treatment with the Ca-secretome (Figure 2b, right panel). All in all, both TJ discontinuities and TJ ruffling, illustrated by zig-zag junctions in IEC were correlated to an increase in the permeability of epithelial layers, as previously reported.⁴¹ Then, the ZO-1 distribution was specified (Figures 2c, S6) by quantifying the local fluorescence distribution at the cell-cell contact zone of the IEC. For both infection and treatment with Ca-secretome conditions, image analysis of the membrane segments confirmed the wider distribution of the ZO-1 signal at the cell-cell contact area compared to the untreated condition, for which ZO-1 was focused on a narrower area (Figure 2c).

Furthermore, to specify the biochemical nature of C. albicans molecules involved in TJ alteration, the Fourier transform infrared (FTIR) spectra of the supernatants were compared to the medium used for its culture (Figure S7b). The supernatants presented lower absorbances within wavelength ranges corresponding to polysaccharides (950–1200 cm⁻¹) and lipids (2750–3000 cm⁻¹), potentially correlated with their consumption by growing fungal cells. In contrast, a higher absorbance was detected within the wavelength range corresponding to amide bonds and, by extension to proteins and peptides (1200–1750 cm⁻¹). This also correlated to an increase in the absorbance at 280 nm, corresponding to the wavelength of aromatic amino acids (Figure S7a). In addition, the supernatant fractions from 3 to 10 kDa induced a similar increase in barrier permeability compared to IEC treated with the complete Ca-secretome, which was not observed when testing protein fractions above 10 kDa (Figure 3a).

Finally, given the importance of the Kex2 endopeptidase machinery for the secretion of peptides crucial for C. albicans pathobiology,³¹,⁴²⁻⁴⁴ supernatants obtained from a C. albicans kex2Δ/Δ mutant strain (i.e. unable to perform KR-processing of C. albicans peptides) were compared to the supernatants of

<figure><img src="image_25.png" /></figure>

**Figure 3.** Peptides from the C. albicans supernatant are involved in the modulation of monolayer integrity. (a) Identification of the molecular weight range of the molecule of interest. Molecules from the C. albicans supernatant (10⁷ yeasts mL⁻¹, 4 h production) were concentrated by filtration in different fractions based on molecular weight (3–10 kDa, > 10 kDa, > 30 kDa, or > 50 kDa). The ability of each fraction to modulate tissue permeability was evaluated in differentiated Caco-2 seeded on Transwell inserts. The cells were treated with filtered supernatants at the apical chamber for 1 h 30. The results are displayed as the mean ± SEM percentage of variation compared to the untreated condition, and statistical analyses were performed to compare the effect of the treatment with the supernatant fractions to the complete supernatant (Dunn test, ***p < 0.001, n = 3). (b) Identification of the putative proteins of interest as modulator of monolayer integrity through TEER measurement. Supernatants from mutants or from the parental CAI-4 and SC5314 strains were produced (10⁷ yeasts mL⁻¹, 4 h-culture), tested on differentiated Caco-2 monolayers, and seeded on Transwell inserts. The cells were treated with supernatants at the apical chamber for 1 h 30 min. The results are displayed as the mean ± SEM percentage of variation compared to the untreated condition, and statistical analysis was performed comparing supernatants to the control condition (Dunn test, *p* < 0.05, **p** < 0.001, n = 3).
<figure><img src="image_26.png" /></figure>

parental strains (Figure 3b). Notably, the supernatants of *C. albicans* *kex2Δ/Δ* mutant strain were not able to alter gut barrier integrity, indicating the crucial involvement of the Kex2 machinery in generating peptides able to alter TJ function.

Collectively, these results indicate that, at early stages of infection, Kex2-processed peptides are secreted by *C. albicans* are sufficient to alter IEC barrier integrity by targeting tight junctions.

**_The C. albicans GPI-anchored protein Rbt1 is involved in tight junction alteration._**

We then conducted a peptidomic analysis of the *Ca*-secretome aiming at identifying candidate peptides. Three biological replicates of the 3–10 kDa fraction of the *Ca*-secretome were analyzed by MS-based proteomics. We identified 52 peptides belonging to 35 different proteins in all the biological replicates (Table S1). GO term analysis of the identified proteins revealed that they were mainly associated with the membrane, protein-containing complexes, or extracellular region (Figure S8a).

Based on a strategy similar to that previously used by Le Marquer et al.,⁴⁵ an *in silico* analysis of these 35 proteins identified 169 possible peptides processed by the Kex2 endopeptidase. (Figure S8d). Among them, only two matched the actual identified peptides in the *Ca*-secretome (Figure S8e). Interestingly, both peptides belong to the same protein, Rbt1 (Repressed by Tup1), a member of the hyphal wall protein family. Thus, peptides from Rbt1 appeared to be the only candidates responsible for TJ alteration.

The involvement of Rbt1 in altering the permeability of IEC monolayers was first confirmed by showing the absence of paracellular transmigration of LY through IEC infected with the *rbt1Δ/Δ* mutant strain compared to the *Ca*-SC5314 and CAI-4 control strains (Figure 4a). This difference was not due to an altered fitness of the *C. albicans* *rbt1Δ/Δ* mutant strain since all the tested strains had similar growth characteristics (Figure S9). In addition, *rbt1Δ/Δ*-supernatants were not able to increase IEC permeability (TEER measurement) compared to supernatants of both the control strains *Ca*-SC5314 (parental wild-type strain) and CAI-4 (parental strain of the *rbt1Δ/Δ* mutant) (Figure 3b).

The role of Rbt1 was further confirmed by qualitative microscopic observations and quantitative measurements of the distribution of the ZO-1 protein, as previously described in Figure 2b and c, in IEC monolayers infected with *C. albicans* *rbt1Δ/Δ* mutant strain or treated with *C. albicans* *rbt1Δ/Δ*-supernatants compared to control strains (Figure 4b and c). Similar to *Ca*-SC5314 (Figure 2b, central

<figure><img src="image_27.png" /></figure>

**Figure 4.** The *C. albicans* GPI-anchored protein Rbt1 is involved in tight junction alteration. (a) Incapacity of the *rbt1Δ/Δ* mutant strain to increase paracellular permeability at an early stage of infection. The paracellular permeability was assessed on differentiated Caco-2 monolayers seeded on Transwell inserts. The cells were infected with yeast at MOI of 10 in the apical chamber supplemented with LY (1 mg mL⁻¹). After 7 h of infection, the LY concentration in the basal chamber was determined. The results are displayed as the mean ± SEM percentage of variation compared to the uninfected condition, and each dot represents the value of a single experiment (Dunn test, \*\*\*p < 0.001, n > 10). (b) Immunolabelling of the ZO-1 protein in the Caco-2 monolayer after 1 h 30 infection with the *rbt1Δ/Δ* mutant strain or CAI-4 parental strain at MOI of 10 or treatment with *rbt1Δ/Δ* mutant supernatant (10⁷ yeasts mL⁻¹, 4 h-culture). The white arrows highlight cell–cell separation or thickening of ZO-1 signal, while dark arrows highlight spike structures. (c) For the immunolabelling experiment, image analysis was performed as explained in Figure S6. Violin plots display differences in ZO-1 signal dispersion (A.U.). The uncolored violin plot indicates the values displayed in Figure 2c. The higher the value is, the wider is the ZO-1 signal at the cell–cell contact zone. For this representation, more than 35 000 signals were analyzed. The horizontal line represents the median value. Statistical differences were examined by one-tailed T-test; H₀: mean dispersion ≤ mean dispersion for the untreated condition (*p* < 0.01). (b–d, g) The monolayer integrity was assessed using TEER measurement just after adding the treatment and at the end of the incubation period.
<figure><img src="image_28.png" /></figure>

panel), infection of IEC monolayers with the CAI-4 parental strain showed significant alterations in ZO-1 distribution, with many areas displaying signal that was split on each side of the cell-cell contact area (Figure 4b, left panel). In contrast, neither infection with the *C. albicans* *rbt1Δ/Δ* mutant, nor the treatment with *rbt1Δ/Δ*-supernatant triggered a disturbance of ZO-1 distribution (Figure 4b, central and right panels). Surprisingly, when treating IEC with *rbt1Δ/Δ* mutant supernatant, specific structures described as spike structures⁴¹ were observed (Figure 4b, right panel). However, these structures of unspecified origin were previously reported to be not associated with an increase in the permeability of IEC.⁴¹ This is in line with our observations showing the absence of modulation of permeability when treating IEC with *rbt1Δ/Δ*-supernatants (Figure 3b).

Then, ZO-1 distribution was specified by quantifying the local fluorescence distribution at the cell-cell contact zone of the IEC (Figure 4c). While the distribution of ZO-1 was similarly modified whatever the infectious control strains (CAI-4 or *Ca*-SC5314, Figure 4c), image analyses confirmed the microscopic observations detailed above, showing that ZO-1 distribution was not modified in IEC infected with *rbt1Δ/Δ* mutants or treated with *rbt1Δ/Δ*-supernatant compared to the untreated cells. According to the abundance of ECE1 and SAP9 in the secretome, the *ece1ΔΔ* and *sap9-10ΔΔ* mutants were also tested, showing same results as the secretome of the wild-type strain (Figure S10).

In parallel, WB quantification of ZO-1 in Caco-2 treated with *rbt1Δ/Δ*-supernatant showed the absence of ZO-1 modulation (Figure S11).

Collectively, these data indicate that *C. albicans* *rbt1Δ/Δ* mutant as well as *rbt1Δ/Δ*-supernatant are defective in modulating the TJ integrity, highlighting the involvement of Rbt1 in the alteration of epithelial barrier permeability.

**Rbt1 favors the invasion of C. albicans in IEC by altering tight junctions.**

We observed that the *rbt1Δ/Δ* mutant displayed less invasiveness than *Ca*-SC5314 (Figure 5a) despite sharing similar adhesion properties (Figure S12), corroborating that Rbt1 is necessary for invasion by *C. albicans*. We thus evaluated the impact of the TJ alteration by *Ca*-secretomes on *C. albicans* invasiveness. For this purpose, IEC monolayers were primed with supernatants obtained from either *Ca*-SC5314 or the *rbt1Δ/Δ* mutant strain, then the invasiveness of *Ca*-SC5314 was monitored (Figure 5b). Interestingly, the invasiveness of *C. albicans* increased after priming with *Ca*-SC5314 supernatants, which was not observed when priming with *rbt1Δ/Δ* supernatants. Moreover, the increase in *Ca*-SC5314 invasiveness was abolished when IEC monolayers were primed with *Ca*-SC5314 supernatants in the

<figure><img src="image_29.png" /></figure>

**Figure 5.** The *C. albicans* supernatant facilitates yeast invasiveness. (a) The invasive capacity of *Ca*-SC5314, the *rbt1Δ/Δ* mutant strain and its parental CAI-4 strain were measured after 2 h of infection. The results are displayed as the mean ± SEM percentage of invasiveness, and each dot represents the value of a single experiment (100 fungal elements each). Statistical analysis was performed and compared to the *Ca*-SC5314 infection condition (Dunn test, \*p < 0.05, n > 10). (b, c, d, e) Caco-2 monolayers primed for 1 h 30 min with *Ca*-SC5314 or *rbt1Δ/Δ* supernatants were infected for 2 h with *Ca*-SC5314 at MOI of 0.1. The relative contribution of endocytosis or fungal active penetration were evaluated using an endocytosis inhibitor, cytochalasin D (Cyt D) (0.5 µM), or yeasts inhibited 1 h with 0.04% of Thimerosal. Invasiveness corresponds to the percentage of adherent hyphae partially internalized in primed Caco-2 cells (b). The same experiment was then conducted in the presence of Cyt D (c), during infection with inhibited fungus (d), and during infection with inhibited yeast in the presence of Cyt D (e). The results are displayed as the mean ± SEM percentage of invasiveness, and each dot represents the value of a single experiment. Statistical analyses were performed and compared infection conditions to the control condition (Dunn test, \*\*p < 0.01, \*\*\*p < 0.001, n > 10).
<figure><img src="image_30.png" /></figure>

presence of 0.5 µM of the endocytosis inhibitor cytochalasin D (CytoD) (Figure 5c). These observations confirmed that induced endocytosis contributed to the increase in *C. albicans* invasion at early stages of infection in IEC monolayers with altered TJ<sup>11,23,46</sup> In addition, when treating fungal hyphae with Thimerosal, which prevents active penetration but still allows for induced endocytosis,<sup>17</sup> a small proportion of thimerosal treated *Ca-SC5314* cells was still able to be internalized into IEC monolayers primed with supernatants of *Ca-SC5314*. This was not observed in control cells and in IEC monolayers primed with supernatants of the *rbt1Δ/Δ* mutant strain (Figure 5d). These observations are in line with previous observations reporting that IEC displaying altered TJ are still able to internalize *C. albicans* hyphae defective in active penetration by induced endocytosis.<sup>23</sup> Finally, when both CytoD and thimerosal were used, no significant *C. albicans* invasiveness was observed despite impaired tissue permeability (Figure 5e).

Collectively, these observations indicate that altering TJ integrity by priming IEC with *Ca*-secretome increases the invasiveness of the fungus by boosting induced endocytosis of *C. albicans*.

**A single Rbt1 peptide is capable of increasing IEC permeability.**

Proteomic analysis identified two Rbt1 peptides from amino acid locations 61–72 and 227–242, respectively, in the 3–10 kDa fraction of the *Ca*-secretome. Both peptides were framed by lysine-arginine (KR) Kex2 processing sites<sup>45</sup> (Table 3, Figure 6a). The impact of each peptide on barrier integrity (TEER measurement) was tested using synthetic versions (Figure 6b). Only the synthetic peptide <sup>sRbt1</sup><sup>61–72</sup> induced a significant decrease in IEC permeability at a concentration of 100 µM (Figure 6b). Notably, a reduction in TEER values between 15% and 40% is considered to be of biological importance. This finding is in agreement with previously published works documenting that an alteration of the TJ complex correlated to a reduction in TEER varying between 15% and 50%, depending on the molecules tested (palmitic acid, bile acids, cytokines such as interferon gamma and TNF alpha, lactones).<sup>47–51</sup> Surprisingly, the increase in permeability observed when treating IEC with the <sup>sRbt1</sup><sup>61–72</sup> peptide was less pronounced

<figure><img src="image_31.png" /></figure>

**Figure 6.** The putative Kex2-generated Rbt1<sup>61–72</sup> peptide modulates the monolayer integrity but needs the secretome environment to play its full role. (a) Amino acid sequences of the two peptides originating from the Rbt1 protein and identified in MS experiment. Each of them is depicted with the Kex2 machinery cleavage sites (-KR-). (b) Potential modulator role of synthetic peptides sRbt1<sup>61–72</sup> and sRbt1<sup>227–242</sup>. They were tested on TEER of differentiated Caco-2 monolayers seeded on Transwell inserts. Synthetic peptides ranging from 1 to 100 µM were applied to the apical part of IEC. Their scramble versions were tested at 100 µM. The complete supernatant (SN) was used as a control (10<sup>7</sup> yeasts mL<sup>-1</sup>, 4 h-culture). (c) The synthetic peptide sRbt1<sup>61–72</sup> complemented the supernatant of the rbt1Δ/Δ mutant strain to decrease the TEER. (d) The supernatant produced from a rbt1ΔKR mutant strain was compared to supernatant from the wild-type Ca-SC5314 and the rbt1Δ/Δ mutant strain (10<sup>7</sup> yeasts mL<sup>-1</sup>, 4 h-culture). (b–d) Monolayer integrity was assessed using TEER measurement just after adding the treatment and at the end of the incubation period. The results are displayed as the mean ± SEM percentage of variation compared to the untreated condition, and each dot represents the value of a single experiment. Statistical analyses were performed and compared treatments to the control conditions (b,c) or to the wild-type yeast supernatant (d) (Dunn test,*p* < 0.05, **p* < 0.01, ***p* < 0.001, *n* > 10).
<figure><img src="image_32.png" /></figure>

than that observed with the *Ca*-secretome. In addition, supplementation of *C. albicans* *rbt1Δ/Δ*-supernatants with _sRbt1_61–72 at 10 or 100 µM restored the ability of this supernatant to disturb the IEC barrier (Figure 6c). These findings suggest that the physical environment and/or the presence of other candidate molecules were necessary for the _sRbt1_61–72 peptide to have an optimal biological effect. Finally, the requirement of the Kex2 machinery for the release of the active _sRbt1_61–72 peptide was assessed by testing supernatants obtained from a *rbt1ΔKR* mutant strain lacking the KR sites necessary for Kex2-processing of the peptide. As expected, the *rbt1ΔKR* mutant produced supernatants that were not able to alter gut barrier permeability (Figure 6d). Taken together, our data reveal that the peptide Rbt162–72 resulting from Kex2-mediated processing of the Rbt1 protein is an important actor of the modulation of IEC permeability.

Discussion

The consensual model of *C. albicans* translocation through the intestinal barrier is currently described as a stepwise process starting with adhesion and invasion, followed by epithelial damage and loss of epithelial integrity.<sup>12,14</sup> Here, we show that, during the early steps of the infection process, *C. albicans* modulates epithelial permeability by targeting TJ integrity, independent of cellular damage following tissue invasion.

Over the years, the secretion of molecules by *C. albicans* has emerged as an important process for pathogenicity.<sup>37-39</sup> In this study, we report that *C. albicans* supernatants obtained from cultures of wild-type cells increased IEC monolayer permeability. We propose that the alteration of TJ in IEC infected with *C. albicans* occurs through the secretion of active fungal molecules, including secreted peptides. Then, we revealed that the supernatants obtained from the yeast forms had a modulatory effect on TJ strongly suggesting that *C. albicans* hyphae are not essential for the modulation of TJ This is not in line with the observation that the non-filamentous *C. albicans* *efg1Δ/cph1Δ* mutant has no impact on IEC permeability.<sup>16</sup> These apparently divergent observations were reconciled after we discovered the involvement of the Rbt1 protein in TJ alteration since the transcription factor Efg1 is necessary for *RBT1* expression.<sup>30,52</sup> The fact that we did not observe any alteration of TJs permeability by using other *C. albicans* mutant strains unable to release pathogenic *C. albicans* factors (i.e. Ece1 and Sap9-10) strengthen our observations that the phenotype we observed is specific to Rbt1.

However, it was unexpected that two peptides of the Rbt1 protein were identified in supernatants from *C. albicans* yeast cell cultures. In fact, Rbt1 is known to be a member of a hyphal cell wall protein family, and it is reported to be specifically expressed by *C. albicans* hyphae.<sup>24-26</sup> We provide evidence in this study that the Golgi serine protease Kex2 is involved in Rbt1 processing. Kex2-processing is widely shared in the fungal kingdom, from *Basidiomycotae* to *Ascomycotae*, and from filamentous to non-filamentous members, including *Candida* species and *Saccharomyces cerevisiae*, confirming that the processing by Kex2 is not restricted to a single morphotype.<sup>42,45</sup> For instance, the maturation of Ywp1, a yeast wall protein member in *C. albicans*, requires Kex2 processing.<sup>43</sup> Interestingly, in our experiments, the Ywp1 peptide (-RLMGETPI-), which has been previously identified as part of a Kex2-processed peptide of Ywp1 and proposed as a spacer rather than a bioactive peptide,<sup>43</sup> was detected in MS analyses of *C. albicans* supernatants. This proves that the Kex2 machinery was active in the experimental setting. We propose that the production of the Rbt1<sup>62-72</sup> peptide occurs in both morphological stages of *C. albicans*. This is supported by previous observations by Monniot et al. reported the intracellular presence of Rbt1 protein in yeast form in addition to the cell wall of hyphal forms.<sup>25</sup> Moreover, as the fate of the protein is cell wall localization, Rbt1 is transported through the Golgi apparatus, where it can be processed by machinery.<sup>53-55</sup>

Interestingly, only a single Rbt1 peptide, Rbt1<sup>61–72</sup>, was identified able to modulate IEC monolayer permeability. However, the effect of the peptide was lower when compared to the complete supernatant prepared from cultures of the wild-type *Ca*-SC5314. Finally, when the supernatant of the *rbt1Δ/Δ* mutant was mixed to the synthetic peptide, alterations of the monolayer permeability were similar to the one observed with supernatants of *Ca*-SC5314 cultures, suggesting that other factors present in the supernatant contribute to the modulatory effect of the Rbt1<sup>61–72</sup> peptide.

Regarding the potential physiological role of secreted peptides by *C. albicans*, it is important to note that even if the Rbt1 protein is present in most *Candida* species, in silico analysis revealed that Kex2 sites
<figure><img src="image_33.png" /></figure>

allowing the processing of the Rbt1<sup>61-72</sup> peptide are found mainly in *C. albicans*. Moreover, in some *C. albicans* strains or in very few other *Candida* species that display the homologous region of Rbt1<sup>61-72</sup>, the alanine 66 residue is replaced by a valine residue. Thus, it is plausible that this peptide is specific to *C. albicans*, indicating that this virulence trait is also specific to this fungus and can have evolutionary importance with specific virulence factor. This importance is supported by our observations reporting lower invasiveness of the *C. albicans rbt1Δ/Δ* mutant strain compared to the wild-type strain, corroborating previous studies using mice models of disseminated candidiasis where the *rbt1Δ/Δ* mutant strain was defective in pathogenicity.<sup>30</sup>

Finally, the results of this study are in line with our previous observations showing the invasion potentiation of *C. albicans*, notably by triggering the endocytic machinery, when the TJ complex of IEC monolayers is pharmacologically altered.<sup>23</sup> Here, we show that alterations of the tight junction complex occur, at least in part, through the *C. albicans*-secreted peptide Rbt1<sup>61-72</sup>. Consequently, this alteration facilitates the interaction between hyphal forms of the fungus with the multiprotein complex c-Met – E-cadherin—EGFR/Her2 necessary for triggering induced endocytosis of *C. albicans*, which then potentiates epithelial invasion by *C. albicans*.<sup>15</sup>

## Limitations of the study

Here, we used the Caco-2 cell monolayer to study intestinal epithelial permeability in the context of the interaction of *C. albicans* with the gut barrier. More complex models that were recently developed (e.g. co-culture models, linearized organoids, and microphysiological systems) could be considered more relevant to mimic in vivo-like barrier features,<sup>56</sup> but they remain difficult to implement and use. In addition, our goals were to specify the molecular mechanisms by which *Candida albicans* deals with enterocytes, independent of the presence of other factors (e.g. the mucus, microbiome, immune cells, etc.) that may interfere with such molecular processes. In this context, the Caco-2 cell monolayer is still considered as a gold standard tool for an enterocyte *in vitro* model for assessing intestinal permeability.<sup>57</sup> Although it is widely regarded as a good predictive tool for passive paracellular diffusion, several technical caveats must be considered to avoid misleading results. First, passage number and culture duration exert strong effects on barrier properties; therefore, we previously characterized this model in our hands by evaluating culture parameters on cell differentiation in both insert or cover slide models.<sup>23</sup> This allowed us to drive several previous studies using this model.<sup>17,23,58,59</sup> Second, considering that cell batch, media and supplementation, substrate/coating materials, and different handling (e.g. TEER measurement protocols) exert strong effects on cellular differentiation and consequently barrier properties, we have improved our protocols by compiling and respecting all the recommendations depicted by both the ATCC and Hubatsch in Nature Protocols.<sup>57</sup> Additionally, the differentiation of each batch of cells was objectified either by measuring, for each insert, the TEER for tissue permeability to ions<sup>60</sup> or by arguing the presence of mature TJ by quantifying the ZO-1 protein by WB or microscopic observations in cover slides, as suggested by Hubatsch.<sup>57</sup> Models that recapitulate the mucus layer or the mechanical forces exerted by flow and peristalsis will be useful to complete our knowledge on Rbt1 effects on the intestinal barrier in future studies.

## Conclusion

We report the discovery of a new strategy developed by *C. albicans* to circumvent the protective role of TJ protein complexes through the secretion of peptides. Moreover, we identified a new virulence function of *C. albicans* Rbt1 protein, which, together with other molecules of the fungal secretome, such as Ece1 and Saps, plays a crucial role in initiating invasion and translocation of the fungal pathogen *C. albicans* through the gut barrier.<sup>24-26</sup>

## Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.
<figure><img src="image_34.png" /></figure>

## Acknowledgments

Thierry Mourer was a recipient of the Pasteur-Cantarini postdoctoral fellowship from the Institut Pasteur. We thank S.G. Filler, Y. Wang and A.P. Mitchell for providing the mutant strains. We thank Christian Coelho for his valuable advice during the physical analysis by ATR-FTIR experiments. We thank Suzanne Rankin from the Dijon-Bourgogne University Hospital for editing the English language of the manuscript.

## Author contributions

F.D. and F.B. designed the research; H.B., A.D., T.P., A.L., G.L., S.K-J., Y.C., I.T., S.T., B.G., S.H., P.L., and L.B., performed the research; T.M., S.B-B., C.D., and B.H. contributed to the construction/providing mutant strains; H.B. analyzed the omics data; A.D., L.B., and P.L. visualized the microscopic data; and H.B. and F.B. F.D. wrote the paper. All the authors contributed to proofreading the paper.

## Funding details

This work was supported by the University of Burgundy and the Dijon-Bourgogne University Hospital François Mitterrand, Dijon, France, by grants from the Agence Nationale de la Recherche (KANJI, ANR-08-MIEN-033-01) and a BIOASTER-Sanofi-Alliance pour les Sciences de la Vie et de la Santé (AVIESAN) joint program (Candida-BAP110) to Frédéric Dalle. This research project has received funding from the French Government through the Investissement d'Avenir program (ANR-10-AIRT-03) to Frédéric Dalle and (Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases, ANR-10-LABX-62-IBEID) to Christophe d'Enfert.

## ORCID

Hervé Bègue ID 0000-0002-9366-8653

Tracy Paradis ID 0009-0003-7077-1767

Géraldine Lucchi ID 0000-0003-2103-486X

Sylvie Kieffer-Jaquinod ID 0000-0003-1281-758X

Yohann Coute ID 0000-0003-3896-6196

Bernhard Hube ID 0000-0002-6028-0425

Ilias Theodorou ID 0000-0001-8508-9558

Sophie Thenet ID 0000-0002-0336-2942

Benjamin Gillet ID 0000-0002-6610-4537

Sandrine Hughes ID 0000-0003-3932-9180

Pierre Lapaquette ID 0000-0002-2680-351X

Louise Basmaciyan ID 0000-0003-4214-8022

Sophie Bachellier-Bassi ID 0000-0003-3970-4825

Christophe d'Enfert ID 0000-0002-6235-3886

Fabienne Bon ID 0000-0003-1519-5720

Frédéric Dalle ID 0000-0001-8849-7514

## References

1. Bassetti M, Trecarichi EM, Righi E, Sanguinetti M, Bisio F, Posteraro B, Soro O, Cauda R, Viscoli C, Tumbarello M. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis. 2007;58(3):325-331. doi: 10.1016/j.diagmicrobio.2007.01.005.

2. Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg D, Chawla V, Young J, Hadley S. Factors associated with candidemia caused by non-albicans *Candida* species versus *Candida albicans* in the intensive care unit. Clin Infect Dis. 2008;46(8):1206-1213. doi: 10.1086/529435.

3. Dadar M, Tiwari R, Karthik K, Chakraborty S, Shahali Y, Dhama K. *Candida albicans* – biology, molecular characterization, pathogenicity, and advances in diagnosis and control – an update. Microb Pathog. 2018;117:128-138. doi: 10.1016/j.micpath.2018.02.028.

4. Klingspor L, Tortorano AM, Peman J, Willinger B, Hamal P, Sendid B, Velegraki A, Kibbler C, Meis JF, Sabino R, et al. Invasive *Candida* infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008). Clin Microbiol Infect. 2015;21(1):87.e1-87.e10. doi: 10.1016/j.cmi.2014.08.011.

5. Mba IE, Nweze EI. Mechanism of *Candida* pathogenesis: revisiting the vital drivers. Eur J Clin Microbiol Infect Dis. 2020;39(10):1797-1819. doi: 10.1007/s10096-020-03912-w.

6. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133-163. doi: 10.1128/CMR.00029-06.
<figure><img src="image_35.png" /></figure>

7 Yapar N. Epidemiology and risk factors for invasive candidiasis. TCRM. 2014;10:95. doi: 10.2147/TCRM.S40160.

8 Koh AY, Köhler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for *Candida albicans* dissemination. PLoS Pathog. 2008;4(2):e35. doi: 10.1371/journal.ppat.0040035.

9 Yang Y-L. Virulence factors of *Candida* species. J Microbiol Immunol Infect. 2003;36(4):223-228.

10 Basmaciyan L, Bon F, Paradis T, Lapaquette P, Dalle F. *Candida albicans* interactions with the host: crossing the intestinal epithelial barrier. Tissue Barriers. 2019;7(2):1612661. doi: 10.1080/21688370.2019.1612661.

11 Wächtler B, Wilson D, Haedicke K, Dalle F, Hube B. From attachment to damage: defined genes of *Candida albicans* mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One. 2011;6(2): e17046. doi: 10.1371/journal.pone.0017046.

12 Allert S, Förster TM, Svensson C-M, Richardson JP, Pawlik T, Hebecker B, Rudolphi S, Juraschitz M, Schaller M, Blagojevic M, et al. *Candida albicans*-Induced epithelial damage mediates translocation through intestinal barriers. mBio. 2018;9(3), e00915-18. doi: 10.1128/mBio.00915-18.

13 Dunker C, Polke M, Schulze-Richter B, Schubert K, Rudolphi S, Gressler AE, Pawlik T, Prada Salcedo JP, Niemiec MJ, Slesiona-Künzel S, et al. Rapid proliferation due to better metabolic adaptation results in full virulence of a filament-deficient *Candida albicans* strain. Nat Commun. 2021;12(1):3899. doi: 10.1038/s41467-021-24095-8.

14 Sprague JL, Kasper L, Hube B. From intestinal colonization to systemic infections: *Candida albicans* translocation and dissemination. Gut Microbes. 2022;14(1), 2154548. doi: 10.1080/19490976.2022.2154548.

15 Phan QT, Solis NV, Cravener MV, Swidergall M, Lin J, Huang MY, Liu H, Singh S, Ibrahim AS, Mazzone M, et al. *Candida albicans* stimulates formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection. PLoS Pathog. 2023;19(8), e1011579. doi: 10.1371/journal.ppat.1011579.

16 Böhringer M, Pohlers S, Schulze S, Albrecht-Eckardt D, Piegsa J, Weber M, Martin R, Hünniger K, Linde J, Guthke R, et al. *Candida albicans* infection leads to barrier breakdown and a MAPK/NF-κB mediated stress response in the intestinal epithelial cell line C2BBe1: epithelial barrier breakdown by *C. albicans*. Cell Microbiol. 2016;18(7):889-904. doi: 10.1111/cmi.12566.

17 Dalle F, Wächtler B, L'Ollivier C, Holland G, Bannert N, Wilson D, Labruère C, Bonnin A, Hube B. Cellular interactions of *Candida albicans* with human oral epithelial cells and enterocytes. Cell Microbiol. 2010;12(2):248-271. doi: 10.1111/j.1462-5822.2009.01394.x.

18 Frank CF, Hostetter MK. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by *Candida albicans*. Transl Res. 2007;149(4):211-222. doi: 10.1016/j.trsl.2006.11.006.

19 Naglik JR, Gaffen SL, Hube B. Candidalysin: discovery and function in *Candida albicans* infections. Curr Opin Microbiol. 2019;52:100-109. doi: 10.1016/j.mib.2019.06.002.

20 Sprague JL, Schille TB, Allert S, Trümper V, Lier A, Großmann P, Priest EL, Tsavou A, Panagiotou G, Naglik JR, et al. *Candida albicans* translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκB-mediated barrier protection. PLoS Pathog. 2024;20(3), e1012031. doi: 10.1371/journal.ppat.1012031.

21 Villar CC, Zhao XR. *Candida albicans* induces early apoptosis followed by secondary necrosis in oral epithelial cells. Mol Oral Microbiol. 2010;25(3):215-225. doi: 10.1111/j.2041-1014.2010.00577.x.

22 Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE, Filler SG. Als3 is a *Candida albicans* invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 2007;5(3):e64. doi: 10.1371/journal.pbio.0050064.

23 Goyer M, Loiselet A, Bon F, L'Ollivier C, Laue M, Holland G, Bonnin A, Dalle F. Intestinal cell tight junctions limit invasion of *candida albicans* through active penetration and endocytosis in the early stages of the interaction of the fungus with the intestinal barrier. PLoS One. 2016;11(3):e0149159. doi: 10.1371/journal.pone.0149159.

24 Ene IV, Bennett RJ. Hwp1 and related adhesins contribute to both mating and biofilm formation in *Candida albicans*. Eukaryot Cell. 2009;8(12):1909-1913. doi: 10.1128/EC.00245-09.

25 Monniot C, Boisramé A, Da Costa G, Chauvel M, Sautour M, Bougnoux M-E, Bellon-Fontaine M-N, Dalle F, d'Enfert C, Richard ML. Rbt1 Protein domains analysis in *Candida albicans* brings insights into hyphal surface modifications and rbt1 potential role during adhesion and biofilm formation. PLoS One. 2013;8(12):e82395. doi: 10.1371/journal.pone.0082395.

26 Padder SA, Ramzan A, Tahir I, Rehman RU, Shah AH. Metabolic flexibility and extensive adaptability governing multiple drug resistance and enhanced virulence in *Candida albicans*. Crit Rev Microbiol. 2022;48(1):1-20. doi: 10.1080/1040841X.2021.1935447.

27 Gillum AM, Tsay EYH, Kirsch DR. Isolation of the *Candida albicans* gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Molec Gen Genet. 1984;198(1):179-182. doi: 10.1007/BF00328721.

28 Walther A, Wendland J. An improved transformation protocol for the human fungal pathogen *Candida albicans*. Curr Genet. 2003;42(6):339-343. doi: 10.1007/s00294-002-0349-0.

29 Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in *Candida albicans*. Genetics. 1993;134(3):717-728. doi: 10.1093/genetics/134.3.717.

30 Braun BR, Head WS, Wang MX, Johnson AD. Identification and characterization of TUP1-regulated genes in *Candida albicans*. Genetics. 2000;156(1):31-44. doi: 10.1093/genetics/156.1.31.
<figure><img src="image_36.png" /></figure>

31 Newport G, Agabian N. KEX2 influences *Candida albicans* proteinase secretion and hyphal formation. *J Biol Chem.* 1997;272(46):28954-28961. doi: 10.1074/jbc.272.46.28954.

32 Lamaze C, Fujimoto LM, Yin HL, Schmid SL. The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. *J Biol Chem.* 1997;272(33):20332-20335. doi: 10.1074/jbc.272.33.20332.

33 Johnson PH, Frank D, Costantino HR. Discovery of tight junction modulators: significance for drug development and delivery. *Drug Discov Today.* 2008;13(5-6):261-267. doi: 10.1016/j.drudis.2007.10.023.

34 Ranaldi G, Consalvo R, Sambuy Y, Scarino ML. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media. *Toxicol In Vitro.* 2003;17(5-6):761-767. doi: 10.1016/S0887-2333(03)00095-X.

35 Moyes DL, Murciano C, Runglall M, Kohli A, Islam A, Naglik JR. Activation of MAPK/c-Fos induced responses in oral epithelial cells is specific to *Candida albicans* and Candida dubliniensis hyphae. *Med Microbiol Immunol.* 2012;201(1):93-101. doi: 10.1007/s00430-011-0209-y.

36 Krug SM, Schulzke JD, Fromm M. Tight junction, selective permeability, and related diseases. *Semin Cell Dev Biol.* 2014;36:166-176. doi: 10.1016/j.semcdb.2014.09.002.

37 Martínez-López R, Hernández ML, Redondo E, Calvo G, Radau S, Pardo M, Gil C, Monteoliva L. *Candida albicans* hyphal extracellular vesicles are different from yeast ones, carrying an active proteasome complex and showing a different role in host immune response. *Microbiol Spectr.* 2022;10(3):e0069822. doi: 10.1128/spectrum.00698-22.

38 Moyes DL, Wilson D, Richardson JP, Mogavero S, Tang SX, Wernecke J, Höfs S, Gratacap RL, Robbins J, Runglall M, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. *Nature.* 2016;532(7597):64-68. doi: 10.1038/nature17625.

39 Wang W, Deng Z, Wu H, Zhao Q, Li T, Zhu W, Wang X, Tang L, Wang C, Cui S-Z, et al. A small secreted protein triggers a TLR2/4-dependent inflammatory response during invasive *Candida albicans* infection. *Nat Commun.* 2019;10(1):1015. doi: 10.1038/s41467-019-08950-3.

40 Assimakopoulos SF, Papageorgiou I, Charonis A. Enterocytes' tight junctions: from molecules to diseases. *World J Gastrointest Pathophysiol.* 2011;2(6):123-137. doi: 10.4291/wjgp.v2.i6.123.

41 Lynn KS, Peterson RJ, Koval M. Ruffles and spikes: control of tight junction morphology and permeability by claudins. *Biochim Biophys Acta Biomembr.* 2020;1862(9): 183339. doi: 10.1016/j.bbamem.2020.183339.

42 Bader O, Krauke Y, Hube B. Processing of predicted substrates of fungal Kex2 proteinases from *Candida albicans*, *C. glabrata*, *Saccharomyces cerevisiae* and *Pichia pastoris*. *BMC Microbiol.* 2008;8:116. doi: 10.1186/1471-2180-8-116.

43 Granger BL. Propeptide genesis by Kex2-dependent cleavage of yeast wall protein 1 (Ywp1) of *Candida albicans*. *PLoS One*. 2018;13(11):e0207955. doi: 10.1371/journal.pone.0207955.

44 Newport G, Kuo A, Flattery A, Gill C, Blake JJ, Kurtz MB, Abruzzo GK, Agabian N. Inactivation of Kex2p diminishes the virulence of *Candida albicans*. *J Biol Chem.* 2003;278(3):1713-1720. doi: 10.1074/jbc.M209713200.

45 Le Marquer M, San Clemente H, Roux C, Savelli B, Frei Dit Frey N. Identification of new signalling peptides through a genome-wide survey of 250 fungal secretomes. *BMC Genom.* 2019;20(1):64. doi: 10.1186/s12864-018-5414-2.

46 Phan QT, Eng DK, Mostowy S, Park H, Cossart P, Filler SG. Role of endothelial Cell Septin 7 in the endocytosis of *Candida albicans*. *mBio.* 2013;4(6):00542-13. doi: 10.1128/mbio.00542-13.

47 Aguanno D, Coquant G, Postal BG, Osinski C, Wieckowski M, Stockholm D, Grill J-P, Carrière V, Seksik P, Thenet S. The intestinal quorum sensing 3-oxo-C12:2 Acyl homoserine lactone limits cytokine-induced tight junction disruption. *Tissue Barriers.* 2020;8(4):1832877. doi: 10.1080/21688370.2020.1832877.

48 Ghezzal S, Postal BG, Quevrain E, Brot L, Seksik P, Leturque A, Thenet S, Carrière V. Palmitic acid damages gut epithelium integrity and initiates inflammatory cytokine production. *Biochim Biophys Acta Mol Cell Biol Lipids.* 2020;1865(2):158530. doi: 10.1016/j.bbalip.2019.158530.

49 Postal BG, Ghezzal S, Aguanno D, André S, Garbin K, Genser L, Brot-Laroche E, Poitou C, Soula H, Leturque A, et al. AhR activation defends gut barrier integrity against damage occurring in obesity. *Mol Metab.* 2020;39 101007. doi: 10.1016/j.molmet.2020.101007.

50 Raimondi F, Santoro P, Barone MV, Pappacoda S, Barretta ML, Nanayakkara M, Apicella C, Capasso L, Paludetto R. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. *Am J Physiol Gastrointest Liver Physiol.* 2008;294(4):G906-913. doi: 10.1152/ajpgi.00043.2007.

51 Rothen-Rutishauser B, Riesen FK, Braun A, Günthert M, Wunderli-Allenspach H. Dynamics of tight and adherens junctions under EGTA treatment. *J Membr Biol.* 2002;188(2):151-162. doi: 10.1007/s00232-001-0182-2.

52 Braun BR, Johnson AD. TUP1, CPH1 and EFG1 make independent contributions to filamentation in *Candida albicans*. *Genetics.* 2000;155(1):57-67. doi: 10.1093/genetics/155.1.57.

53 Heiman MG, Engel A, Walter P. The Golgi-resident protease Kex2 acts in conjunction with Prm1 to facilitate cell fusion during yeast mating. *J Cell Biol.* 2007;176(2):209-222. doi: 10.1083/jcb.200609182.

54 Park K, Ju S, Kim N, Park S-Y. The Golgi complex: a hub of the secretory pathway. *BMB Rep.* 2021;54(5):246-252. doi: 10.5483/BMBRep.2021.54.5.270.

55 Redding K, Holcomb C, Fuller RS. Immunolocalization of Kex2 protease identifies a putative late Golgi compartment in the yeast *Saccharomyces cerevisiae*. *J Cell Biol.* 1991;113(3):527-538. doi: 10.1083/jcb.113.3.527.
<figure><img src="image_37.png" /></figure>

56 Moyer HL, Vergara L, Stephan C, Sakolish C, Lin H-C, Chiu WA, Villenave R, Hewitt P, Ferguson SS, Rusyn I. Human Small intestinal tissue models to assess barrier permeability: comparative analysis of Caco-2 cells, jejunal and duodenal enteroid-derived cells, and EpiIntestinal™ tissues in membrane-based cultures with and without flow. Bioengineering. 2025;12(8):809. doi: 10.3390/bioengineering12080809.

57 Hubatsch I, Ragnarsson EGE, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc. 2007;2(9):2111-2119. doi: 10.1038/nprot.2007.303.

58 Albac S, Schmitz A, Lopez-Alayon C, d'Enfert C, Sautour M, Ducreux A, Labruère-Chazal C, Laue M, Holland G, Bonnin A, et al. Candida albicans is able to use M cells as a portal of entry across the intestinal barrier in vitro. Cell Microbiol. 2016;18(2):195-210. doi: 10.1111/cmi.12495.

59 Lapaquette P, Ducreux A, Basmaciyan L, Paradis T, Bon F, Bataille A, Winckler P, Hube B, d'Enfert C, Esclatine A, et al. Membrane protective role of autophagic machinery during infection of epithelial cells by Candida albicans. Gut Microbes. 2022;14(1), 2004798. 10.1080/19490976.2021.2004798.

60 Postal BG, Aguanno D, Thenet S, Carrière V. Rapid evaluation of intestinal paracellular permeability using the human enterocytic-like Caco-2/TC7 cell line. Methods Mol Biol. 2021;2367:13-26. doi: 10.1007/7651_2021_366.